Volume 35, Issue 28, 21 July 2014

CardioPulse Articles

• Extract
• View article

Heparin bridging in peri-procedural management of new oral anticoagulant: a bridge too far?

• Extract
• View article

Is there a period of liability with initiation of warfarin in patients with atrial fibrillation?

• Extract
• View article

Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism

• Abstract
• View article

Edoxaban: a focused review of its clinical pharmacology

• Abstract
• View article
• Supplementary data

An unusual cause of dyspnoea in a young man

• Extract
• View article
• Supplementary data

Efficacy and safety of apixaban compared with aspirin in patients who previously tried but failed treatment with vitamin K antagonists: results from the AVERROES trial

• Abstract
• View article
• Supplementary data

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

• Abstract
• View article

Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial

• Abstract
• View article

Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes

• Abstract
• View article
• Supplementary data

ECG pitfall: anterior myocardial infarction in dextrocardia

• Extract
• View article

Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

• Abstract
• View article
• Supplementary data

Hypertrophic cardiomyopathy and Anderson–Fabry disease: unravelling septal hypertrophy with T1-mapping CMR

• Extract
• View article

Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation

• Abstract
• View article
• Supplementary data